GPATCH2L

gene
On this page

Also known as FLJ20689FLJ10033

Summary

GPATCH2L (G-patch domain containing 2 like, HGNC:20210) is a protein-coding gene on chromosome 14q24.3, encoding G patch domain-containing protein 2-like (Q9NWQ4).

Predicted to be active in nucleus.

Source: NCBI Gene 55668 — RefSeq curated summary.

At a glance

  • GWAS associations: 10
  • Clinical variants (ClinVar): 45 total
  • MANE Select transcript: NM_017926

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20210
Approved symbolGPATCH2L
NameG-patch domain containing 2 like
Location14q24.3
Locus typegene with protein product
StatusApproved
AliasesFLJ20689, FLJ10033
Ensembl geneENSG00000089916
Ensembl biotypeprotein_coding
Entrez55668

Gene structure

Transcript identifiers

Ensembl transcripts: 16 — 11 protein_coding, 2 retained_intron, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000261530, ENST00000312858, ENST00000553588, ENST00000554125, ENST00000554375, ENST00000554799, ENST00000556109, ENST00000556372, ENST00000556663, ENST00000556675, ENST00000557207, ENST00000557263, ENST00000557542, ENST00000621494, ENST00000930299, ENST00000954001

RefSeq mRNA: 9 — MANE Select: NM_017926 NM_001322026, NM_001322027, NM_001322028, NM_001322029, NM_001322030, NM_001322031, NM_001322032, NM_017926, NM_017972

CCDS: CCDS9848, CCDS9849

Canonical transcript exons

ENST00000261530 — 10 exons

ExonStartEnd
ENSE000025339017615192276151991
ENSE000026039767620169176214343
ENSE000035350647617354676173625
ENSE000035649007619587876195972
ENSE000035676997615435476155025
ENSE000036173227617184376172019
ENSE000036392677618076476180849
ENSE000036419797617798876178042
ENSE000036426777617662376176690
ENSE000036864207616666376166727

Expression profiles

Bgee: expression breadth ubiquitous, 259 present calls, max score 95.50.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 17.6731 / max 181.5289, expressed in 1803 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
14071016.99231802
1407150.4765239
1407110.197573
2073060.00682

Top tissues by expression

286 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
buccal mucosa cellCL:000233695.50gold quality
colonic epitheliumUBERON:000039791.38gold quality
adrenal tissueUBERON:001830390.78gold quality
monocyteCL:000057688.98gold quality
cauda epididymisUBERON:000436088.65gold quality
mononuclear cellCL:000084288.63gold quality
calcaneal tendonUBERON:000370188.49gold quality
leukocyteCL:000073888.05gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047387.33gold quality
stromal cell of endometriumCL:000225587.01gold quality
cortical plateUBERON:000534386.59gold quality
ganglionic eminenceUBERON:000402385.89gold quality
right testisUBERON:000453485.87gold quality
corpus epididymisUBERON:000435985.81gold quality
caput epididymisUBERON:000435885.72gold quality
gall bladderUBERON:000211085.66gold quality
ventricular zoneUBERON:000305385.63gold quality
left testisUBERON:000453385.39gold quality
sural nerveUBERON:001548884.98gold quality
corpus callosumUBERON:000233684.96gold quality
islet of LangerhansUBERON:000000684.77gold quality
rectumUBERON:000105284.44gold quality
testisUBERON:000047384.43gold quality
tendonUBERON:000004384.22gold quality
gastrocnemiusUBERON:000138884.08gold quality
tonsilUBERON:000237283.98gold quality
muscle of legUBERON:000138383.97gold quality
right atrium auricular regionUBERON:000663183.97gold quality
bone marrowUBERON:000237183.63gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099183.53gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes8.16

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

239 targeting GPATCH2L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-4768-5P100.0069.492861
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-6873-3P100.0071.422626
HSA-MIR-429100.0073.442698
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-188-3P100.0068.761240
HSA-MIR-126-5P100.0072.713180
HSA-MIR-8485100.0077.574731
HSA-MIR-196A-1-3P99.9972.152772
HSA-MIR-548AW99.9972.573559
HSA-MIR-366299.9973.825684
HSA-MIR-428299.9975.366408
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-186-5P99.9970.833707
HSA-MIR-33A-5P99.9968.621055
HSA-MIR-33B-5P99.9968.581062
HSA-MIR-548AN99.9770.912817
HSA-MIR-314899.9775.066478
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-590-3P99.9674.346478
HSA-MIR-211099.9666.681930
HSA-MIR-971899.9468.91918
HSA-MIR-335-3P99.9373.364958
HSA-MIR-218-5P99.9372.222103

Literature-anchored findings (GeneRIF, showing 1)

  • N6-methyladenosine hypomethylation of circGPATCH2L regulates DNA damage and apoptosis through TRIM28 in intervertebral disc degeneration. (PMID:37438603)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusGpatch2lENSMUSG00000021254
rattus_norvegicusGpatch2lENSRNOG00000010227

Paralogs (1): GPATCH2 (ENSG00000092978)

Protein

Protein identifiers

G patch domain-containing protein 2-likeQ9NWQ4 (reviewed: Q9NWQ4)

All UniProt accessions (7): Q9NWQ4, G3V290, G3V3M4, G3V4I8, G3V4L1, G3V553, G3V5D0

UniProt curated annotations — full annotation on UniProt →

Isoforms (3)

UniProt IDNamesCanonical?
Q9NWQ4-31yes
Q9NWQ4-12
Q9NWQ4-44

RefSeq proteins (9): NP_001308955, NP_001308956, NP_001308957, NP_001308958, NP_001308959, NP_001308960, NP_001308961, NP_060396, NP_060442 (=MANE)

Domains & families (InterPro)

IDNameType
IPR051189Splicing_assoc_domainFamily

UniProt features (21 total): modified residue 6, compositionally biased region 4, splice variant 3, sequence conflict 3, region of interest 2, chain 1, cross-link 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9NWQ4-F151.190.02

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (7): 91, 447, 449, 196, 31, 86, 88

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 228 (showing top): PEREZ_TP63_TARGETS, TGACCTY_ERR1_Q2, CACCAGC_MIR138, chr14q24, PEREZ_TP53_AND_TP63_TARGETS, CHANDRAN_METASTASIS_UP, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN, STAT1_02, SCGGAAGY_ELK1_02, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, MORI_PLASMA_CELL_DN, STAT1_03, PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN, GHANDHI_DIRECT_IRRADIATION_UP, ODONNELL_METASTASIS_UP

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

702 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
GPATCH2LBLTP3BA0JNW5614
GPATCH2LZNF543Q08ER8505
GPATCH2LIFT43Q96FT9475
GPATCH2LPTPRHQ9HD43458
GPATCH2LSVOPLQ8N434447
GPATCH2LVPS13CQ709C8373
GPATCH2LTTLL5Q6EMB2371
GPATCH2LDHRS7BQ6IAN0371
GPATCH2LPPP1R3EQ9H7J1370
GPATCH2LZNF135P52742351
GPATCH2LMACO1Q8N5G2348
GPATCH2LRRP15Q9Y3B9348
GPATCH2LDHX15O43143345
GPATCH2LAGTPBP1Q9UPW5334
GPATCH2LSACK1AQ86UY5330
GPATCH2LTSEN2Q8NCE0330

IntAct

81 interactions, top by confidence:

ABTypeScore
GPATCH2LZNF398psi-mi:“MI:0915”(physical association)0.670
GPATCH2LZNF473psi-mi:“MI:0915”(physical association)0.670
ZNF398GPATCH2Lpsi-mi:“MI:0915”(physical association)0.670
CSNK2BNMT2psi-mi:“MI:0914”(association)0.660
CSNK2A2PES1psi-mi:“MI:0914”(association)0.640
MEOX2GPATCH2Lpsi-mi:“MI:0915”(physical association)0.560
GPATCH2Lpsi-mi:“MI:0915”(physical association)0.560
GPATCH2LZNF263psi-mi:“MI:0915”(physical association)0.560
ZBTB48GPATCH2Lpsi-mi:“MI:0915”(physical association)0.560
KRTAP10-9GPATCH2Lpsi-mi:“MI:0915”(physical association)0.560
DIP2AGPATCH2Lpsi-mi:“MI:0915”(physical association)0.560
ZNF165GPATCH2Lpsi-mi:“MI:0915”(physical association)0.560
KRT40GPATCH2Lpsi-mi:“MI:0915”(physical association)0.560
GPATCH2LCEP70psi-mi:“MI:0915”(physical association)0.560
TRIM41GPATCH2Lpsi-mi:“MI:0915”(physical association)0.560
GPATCH2LRBPMSpsi-mi:“MI:0915”(physical association)0.560
ZBTB8AGPATCH2Lpsi-mi:“MI:0915”(physical association)0.560
GPATCH2LMDFIpsi-mi:“MI:0915”(physical association)0.560
KRTAP4-12GPATCH2Lpsi-mi:“MI:0915”(physical association)0.560
GPATCH2LLZTS2psi-mi:“MI:0915”(physical association)0.560
PRDM14GPATCH2Lpsi-mi:“MI:0915”(physical association)0.560
ZNF408GPATCH2Lpsi-mi:“MI:0915”(physical association)0.560
THAP1GPATCH2Lpsi-mi:“MI:0915”(physical association)0.560

BioGRID (101): GPATCH2L (Two-hybrid), GPATCH2L (Two-hybrid), GPATCH2L (Two-hybrid), GPATCH2L (Two-hybrid), GPATCH2L (Two-hybrid), GPATCH2L (Two-hybrid), GPATCH2L (Two-hybrid), GPATCH2L (Two-hybrid), GPATCH2L (Two-hybrid), ZNF398 (Two-hybrid), PRDM14 (Two-hybrid), ZNF408 (Two-hybrid), CCDC33 (Two-hybrid), CEP70 (Two-hybrid), KRTAP4-12 (Two-hybrid)

ESM2 similar proteins: A0A087WXM9, A0A140LI88, A2AKY4, A4D1E1, A4IGL8, E5FYH0, E9Q3S4, F6ULY3, F7DF15, G3S077, G7H7V7, G7NY55, O13859, O35923, O54952, O88491, P38299, P38398, P46013, P48754, P51587, P97929, Q09MP3, Q28DZ0, Q4V7J0, Q56UN5, Q5DTW7, Q5F2C3, Q5VWN6, Q5VYV7, Q6J6I8, Q6J6J0, Q6NS59, Q77PU6, Q7TSY8, Q7Z570, Q864S8, Q86TB3, Q86XD8, Q8N7Z5

Diamond homologs: Q6PE65, Q7TQC7, Q9NW75, Q9NWQ4, A0JMV4, A4IGK4, A5DEF8, A5DSB5, A6ZRL6, A7TQN2, B2GV05, F4JCU0, O15226, P52756, P53866, P70501, P98175, Q1RMU5, Q59UG4, Q6BYP9, Q6C233, Q6CQ59, Q6DDU9, Q6FP19, Q75E62, Q7TN31, Q8BY02, Q8CH09, Q8IX01, Q8N302, Q91YE7, Q99KG3, Q9UTK6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

45 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance36
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1657 predictions. Top by Δscore:

VariantEffectΔscore
14:76166186:A:AGdonor_gain1.0000
14:76166661:A:AGacceptor_gain1.0000
14:76166661:AGT:Aacceptor_gain1.0000
14:76166662:G:GGacceptor_gain1.0000
14:76166662:GT:Gacceptor_gain1.0000
14:76166662:GTG:Gacceptor_gain1.0000
14:76166662:GTGAA:Gacceptor_gain1.0000
14:76171840:TAG:Tacceptor_loss1.0000
14:76171841:A:AGacceptor_gain1.0000
14:76171842:G:GGacceptor_gain1.0000
14:76171842:G:GTacceptor_loss1.0000
14:76172017:GAG:Gdonor_gain1.0000
14:76172019:GGTG:Gdonor_loss1.0000
14:76172020:GT:Gdonor_loss1.0000
14:76172021:T:Gdonor_loss1.0000
14:76176689:GA:Gdonor_gain1.0000
14:76176691:G:GGdonor_gain1.0000
14:76180762:A:AGacceptor_gain1.0000
14:76180763:G:GGacceptor_gain1.0000
14:76180763:GTTCA:Gacceptor_gain1.0000
14:76201590:GAT:Gdonor_gain1.0000
14:76166186:A:Gdonor_gain0.9900
14:76166191:T:Gdonor_gain0.9900
14:76166657:TTACA:Tacceptor_loss0.9900
14:76166659:ACAGT:Aacceptor_gain0.9900
14:76166660:C:Gacceptor_gain0.9900
14:76166661:A:ACacceptor_loss0.9900
14:76166662:GTGA:Gacceptor_gain0.9900
14:76166723:ACAAG:Adonor_loss0.9900
14:76166724:CAAG:Cdonor_loss0.9900

AlphaMissense

3152 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
14:76154374:T:CL4P0.999
14:76154386:T:CL8S0.999
14:76154750:G:CR129S0.999
14:76154750:G:TR129S0.999
14:76171849:A:TD245V0.999
14:76171857:A:CS248R0.999
14:76171859:T:AS248R0.999
14:76171859:T:GS248R0.999
14:76171863:T:AW250R0.999
14:76171863:T:CW250R0.999
14:76154398:T:CL12S0.998
14:76154745:C:AR128S0.998
14:76154749:G:CR129T0.998
14:76154749:G:TR129M0.998
14:76154760:A:GK133E0.998
14:76154762:G:CK133N0.998
14:76154762:G:TK133N0.998
14:76166670:A:CS224R0.998
14:76166672:C:AS224R0.998
14:76166672:C:GS224R0.998
14:76166673:A:CS225R0.998
14:76166675:T:AS225R0.998
14:76166675:T:GS225R0.998
14:76171845:G:CD244H0.998
14:76171846:A:TD244V0.998
14:76171848:G:CD245H0.998
14:76171849:A:CD245A0.998
14:76154374:T:AL4Q0.997
14:76154754:A:GK131E0.997
14:76154756:G:CK131N0.997

dbSNP variants (sampled 300 via entrez): RS1000029146 (14:76204695 T>A), RS1000035171 (14:76182127 G>A), RS1000056319 (14:76216251 C>T), RS1000091942 (14:76166588 A>C), RS1000276509 (14:76207891 A>C,G), RS1000309202 (14:76207549 A>G), RS1000361363 (14:76172804 T>C), RS1000391296 (14:76169926 G>A), RS1000428108 (14:76197526 T>C), RS1000438533 (14:76169573 A>T), RS1000535006 (14:76188185 G>A), RS1000559102 (14:76210011 C>T), RS1000561102 (14:76183919 A>G), RS1000580302 (14:76195136 G>A), RS1000608756 (14:76231684 G>A,C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

10 associations (top):

StudyTraitp-value
GCST000094_8Blood pressure5.000000e-06
GCST001320_25Acute lymphoblastic leukemia (childhood)3.000000e-06
GCST001320_29Acute lymphoblastic leukemia (childhood)1.000000e-06
GCST001320_4Acute lymphoblastic leukemia (childhood)4.000000e-06
GCST009391_268Metabolite levels8.000000e-06
GCST010083_350Hemoglobin levels7.000000e-09
GCST012147_7Declining hemoglobin trajectory in blood donors3.000000e-06
GCST90002383_262Hematocrit2.000000e-12
GCST90002384_370Hemoglobin2.000000e-13
GCST90002403_516Red blood cell count1.000000e-09

EFO canonical traits (6, from GWAS)

EFO IDTrait name
EFO:0006336diastolic blood pressure
EFO:0010427triacylglycerol 54:9 measurement
EFO:0004509hemoglobin measurement
EFO:0600027hemoglobin change measurement
EFO:0004348hematocrit
EFO:0004305erythrocyte count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

47 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, increases expression3
trichostatin Aaffects cotreatment, increases expression2
sodium arseniteincreases abundance, increases expression2
Air Pollutantsincreases expression, affects cotreatment, increases abundance2
Arsenicincreases abundance, increases expression, decreases methylation2
Tobacco Smoke Pollutionincreases expression2
Valproic Acidaffects expression, decreases expression2
Particulate Matterincreases abundance, increases expression, decreases expression2
FR900359increases phosphorylation1
TAK-243increases sumoylation1
urushiolincreases expression1
methylmercuric chloridedecreases expression, increases expression1
triphenyl phosphateaffects expression1
alpha-pineneaffects cotreatment, increases expression, increases abundance1
nickel sulfatedecreases expression1
methacrylaldehydeaffects cotreatment, increases expression, increases abundance1
pentanaldecreases expression1
di-n-butylphosphoric acidaffects expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression1
abrineincreases expression1
dorsomorphinaffects cotreatment, increases expression1
(+)-JQ1 compoundincreases expression1
Bortezomibincreases expression1
Irinotecandecreases expression1
Leflunomideincreases expression1
Acetaminophenincreases expression1
Acroleinaffects cotreatment, increases expression, increases abundance1
Vehicle Emissionsdecreases expression, increases abundance1
Caffeineaffects phosphorylation1
Coumestroldecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): acute lymphoblastic leukemia